VCM
IRWD icon

Versant Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Versant Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60
Closed -$88 – 2681
2025
Q1 		$88 Sell
60
-158
-72% -$376 ﹤0.01% 2491
2024
Q4 		$966 Sell
218
-2,586
-92% -$10.5K ﹤0.01% 2201
2024
Q3 		$11.6K Buy
2,804
+2,644
+1,653% +$14.2K ﹤0.01% 1008
2024
Q2 		$1.04K Buy
160
+100
+167% +$707 ﹤0.01% 1667
2024
Q1 		$523 Hold
60
– – ﹤0.01% 1682
2023
Q4 		$686 Hold
60
– – ﹤0.01% 1607
2023
Q3 		$578 Sell
60
-64
-52% -$627 ﹤0.01% 1664
2023
Q2 		$1.32K Buy
124
+64
+107% +$688 ﹤0.01% 1522
2023
Q1 		$631 Hold
60
– – ﹤0.01% 1552
2022
Q4 		$743 Hold
60
– – ﹤0.01% 1368
2022
Q3 		$1K Sell
60
-30
-33% -$340 ﹤0.01% 1260
2022
Q2 		$1K Hold
90
– – ﹤0.01% 1280
2022
Q1 		$1K Buy
90
+30
+50% +$344 ﹤0.01% 1296
2021
Q4 		$1K Hold
60
– – ﹤0.01% 1280
2021
Q3 		$1K Hold
60
– – ﹤0.01% 1286
2021
Q2 		$1K Hold
60
– – ﹤0.01% 1292
2021
Q1 		$1K Hold
60
– – ﹤0.01% 1375
2020
Q4 		$0 Hold
60
– – ﹤0.01% 1429
2020
Q3 		$0 Hold
60
– – ﹤0.01% 1396
2020
Q2 		$0 Sell
60
-20
-25% -$205 ﹤0.01% 1421
2020
Q1 		$0 Sell
80
-13
-14% -$153 ﹤0.01% 1484
2019
Q4 		$1K Sell
93
-42
-31% -$463 ﹤0.01% 1238
2019
Q3 		$1K Buy
135
+5
+4% +$49 ﹤0.01% 1256
2019
Q2 		$1K Sell
130
-44
-25% -$493 ﹤0.01% 1287
2019
Q1 		$1K Buy
+174
New +$1.94K ﹤0.01% 1446

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Versant Capital Management's IRWD Position: Q2 2025 in Review

Versant Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 60 shares — an estimated $88 sold.

Versant Capital Management first reported a position in IRWD in Q1 2019 and held it in 25 quarters. The position peaked at $11.6K in Q3 2024. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Versant Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Versant Capital Management sold 60 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $88.
  • Versant Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 25 quarters.
  • Versant Capital Management's Ironwood Pharmaceuticals position peaked at $11.6K in Q3 2024.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Versant Capital Management's 13F filing for Q2 2025, filed 7 Jul 2025.